Abiopharma

🔍 Zecher Linda Kay (Director)

Company: Tenable Holdings, Inc. (TENB)

Report Date: 2026-08-18

Detailed Transactions and Holdings:

• Sold 700 shares of Common Stock at $35.46 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,702.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 690 shares of Common Stock at $35.76 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,012.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.38 - 35.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.74 - $35.99, inclusive.